bimekizumabsecukinumabAdalimumab
…re on adalimumab, 39 (32.8%) on secukinumab, and five (4.2%) on bimekizumab. Among those on adalimumab, 96.0% follow a weekly regimen, whil…
7articles mentioning drugs
21drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Bimekizumab ×
Bimekizumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Bimekizumab
7 articles · page 1 of 1Bimekizumabaxial spondyloarthritisAnkylosing SpondylitisBE MOBILE 1BE MOVINGShort Form 36 Health Survey
…nal pain and physical function levels were observed.Conclusions Bimekizumab treatment led to rapid and sustained improvements in key patien…
BimekizumabShort Form 36 Health SurveyNumeric Rating Scaleaxial spondyloarthritisaxSpAAnkylosing Spondylitis
…FI: −2.9) and HRQoL (SF-36 PCS: +12.4; ASQoL: −5.6).Conclusions Bimekizumab treatment resulted in sustained improvements in patient-reporte…
bimekizumabpsoriatic arthritisaxial spondyloarthritisaxSpAPsA
…Objective To present updated integrated safety analyses of bimekizumab in patients with axial spondyloarthritis (axSpA) or psoriatic a…
adalimumabbimekizumabsecukinumabHospital Anxiety and Depression Scalegeneral hospitalbiological therapybiological treatmentSuppurative hidradenitis (SH)
…ntre study in SH adult patients receiving biological treatment (adalimumab, secukinumab or bimekizumab) at a general hospital (March-June …
benralizumabadalimumabmepolizumabadalimumab-relatedDenosumabVedolizumabBimekizumab
…pport co-prescribing. We describe our experience of prescribing benralizumab alongside non-SA MAbs at a tertiary centre.Methods We conducted…
BKZBimekizumabnr-axSpAenthesitisr-axSpAPsoriatic Arthritis
…week double-blind, placebo-controlled period, then all received BKZ 160 mg every 4 weeks for 36 weeks. Patients not meeting withdra…